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Summary
Objectives: To perform a requirements analysis of the barriers to con-
ducting research linking of primary care, genetic and cancer data.
Methods: We extended our initial data-centric approach to include
socio-cultural and business requirements. We created reference models
of core data requirements common to most studies using unified mod-
elling language (UML), dataflow diagrams (DFD) and business proc-
ess modelling notation (BPMN). We conducted a stakeholder analysis
and constructed DFD and UML diagrams for use cases based on simu-
lated research studies. We used research output as a sensitivity analysis.
Results: Differences between the reference model and use cases iden-
tified study specific data requirements. The stakeholder analysis
identified: tensions, changes in specification, some indifference from
data providers and enthusiastic informaticians urging inclusion of
socio-cultural context. We identified requirements to collect informa-
tion at three levels: micro- data items, which need to be semantically
interoperable, meso- the medical record and data extraction, and
macro- the health system and socio-cultural issues. BPMN clarified
complex business requirements among data providers and vendors;
and additional geographical requirements for patients to be repre-
sented in both linked datasets. High quality research output was the
norm for most repositories.
Conclusions: Reference models provide high-level schemata of the
core data requirements. However, business requirements’ modelling
identifies stakeholder issues and identifies what needs to be ad-
dressed to enable participation.
Keywords
General practice; medical records systems, computerized; research
design; registry; records as topic
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Introduction
Requirements analyses are part of soft-
ware engineering with the purpose of
reducing the chances of failure or the
need for frequent expensive changes
further along the development path-
way. A requirements analysis is the
process of determining what a system
must do, acknowledging the at times
conflicting needs of the various
stakeholders [1, 2]. Conventionally
conducting a requirements analysis was
an early step in the waterfall approach
to software development [3, 4, 5].
However, "agile" approaches which in-
clude user and stakeholder involvement
throughout development [6] and recog-
nise the need for flexibility and change
[7] have been used more and also com-
bined with the waterfall approach.
Medical research is a complex proc-
ess and although there are many com-
puterised data repositories, they are not
commonly linked in research studies
[8]. These data repositories include:
genetic databases, disease registries,
and, routinely collected primary care
data. Genetic data has been collected
into biobanks since the completion of
the mapping of the human genome [9,
10], though biological specimens have
been used in forensic science for longer
[11, 12]. Cancer registries are also well
established [13, 14] and more recently
have become international and used to
study of a wide range of conditions
[15], and the effectiveness of treat-
ments [16]. Primary care data are also
widely used in research. These data are
rich, collected longitudinally and in
countries with registration systems pro-
vide a population denominator [17, 18].
Research networks have been devel-
oped within primary care, at regional
and national level and have improved
the capability and capacity for research
in primary care; including recruitment
into trials [19, 20]. There are many
models, sometimes they are part of
National or regional sentinel networks
[21], or of single vendor linked data
collection schemes [15].
 There have been a number of at-
tempts to link these different types of
data for research [22, 23, 24, 25], but
the successes have largely been lim-
ited to the use of specif ic methods in
bioinformatics [26, 27].
Objective
We carried out this requirements analy-
sis to identify how to maximise the use
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of IT in conducting complex research
projects linking aggregated primary
care data to a disease registry or a ge-
netic data repository.
Methods
1   Overview
We adopted an agile approach to al-
low for any alterations in the require-
ments as other parts of the project de-
veloped [28]. We simultaneously
conducted a literature review and held
expert consensus workshops [29, 30].
We developed a reference model and
models for data flow and of the busi-
ness process involved. We conducted
a stakeholder analysis that included
interacting with potential data provid-
ers and electronic health record (EHR)
system vendors.
2   TRANSFoRm Research
Programme
This investigation was part of the
TRANSFoRm (Translational Research
and Patient Safety In Europe) research
programme [31]. TRANSFoRm is de-
signed to reduce the barriers to con-
ducting research using routine health
data and promote interoperability be-
tween different health computer sys-
tems so that international data can be
collected about the quality of care and
for research [32]. One element of
TRANSFoRm was a requirements
analysis to assess the feasibility of con-
ducting research studies set out in the
form or use cases.
3   Creating a Reference Model for the
Research Process and Studies
We separately modelled the use case
def ined research studies,  using the
Unif ied Modelling Language (UML)
[33]. We excluded consent and data
privacy issues as they were being dealt
with elsewhere within the project [34].
We developed a schema of the proc-
esses associated with a linked data re-
search project as a reference model
(Figure 1) [35] based on our experi-
ence of extracting, aggregating and
processing routinely collected data [36,
37].  Additionally we recognised that
linked research required the same in-
dividuals to be represented in both
linked databases; as cases present in
only one database could not be used
for linked research. We called this link
a "geographical requirement" (Figure
2) and included it within our business
requirements.
We created UML and data flow dia-
grams (DFD) for the reference model
at a high level of abstraction, so we
could contrast them with individual
study use cases [38, 39, 40].
4   Stakeholder Analysis
We identified the following stakeholder
groups and summarised our findings in
a mind map and stakeholder analysis
grid (Figure 3, Table 2):
(1) End users of the linked datasets; spe-
cifically those looking to run the use
case defined linked-data studies.
(2) Direct and indirect providers of these
data. Direct suppliers include da-
tabase owners or other direct data
providers to a study. We spoke in
depth to ten. Indirect data providers
include those recording or aggregat-
ing data earlier in the process.
(3) The TRANSFoRm study team and
their funders, and
(4) External experts, principally from
the International Medical Infor-
matics Association (IMIA) and Eu-
ropean Federation for Medical
Informatics (EFMI) primary care
informatics working groups.
5   Use Case Testing
We analysed the TRANSFoRm use cases
to define the data requirements and the
integrity of the use cases, constructing a
DFD and UML models for each. The
use cases were in two clinical domains,
type-2 diabetes and acid-reflux related
oesophageal disease. The type-2 diabe-
Fig. 1   Schema of the process involved in conducting a linked data research study
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(Table 2). There were challenges in
getting direct data providers to engage
with the process. We made 316 con-
tacts with data providers we thought
might participate and only 56 (17.7%)
supplied the comprehensive informa-
tion def ined by the requirements
analysis. The proportion of valid re-
sponses from primary care data pro-
viders was 26.4% (29/110); from can-
cer registries 16.9% (15/89); and from
genetic data bases 10.3% (12/117).
Many of the data repositories were re-
gional not national and already sus-
tained by a viable programme of re-
search; most were producing high
grade research output.  Their data
processing systems had grown or-
ganically as EHR systems had be-
come more sophisticated. They were
generally proprietary, not using
standard metadata,  and functioning
as "black boxes" between data entry
and export for research. However, all
could output data in a range of stand-
ard formats.
We identif ied and contacted 17
EHR vendors identif ied through our
initial  searches and a further nine
flagged by stakeholders.  EHR ven-
dors were reluctant to engage unless
there were some chance of benef its
realisation including a priori publica-
tion of criteria for inclusion in future
TRANSFoRm studies. One primary
care EHR system reported it has an
open application programme interface
(API). The lack of open APIs makes
this approach to interaction with EHRs
more challenging as it might require
separate licenced APIs to be developed
with each vendor.
TRANSFoRm investigators had
different perspectives reflecting their
varying backgrounds; they were
largely clinical or information sys-
tems researchers. These differences
were nuanced, but the former gener-
ally described the project as a com-
plex clinical process, while the lat-
ter looked to rationalise things into
machine processable activities.  The
TRANSFoRm senior investigators
were trying to co-ordinate the "big
Fig. 2   BPMN schema of the key business decisions which inform whether a data repository is likely to participate in a TRANSFoRm research study
tes cohort study explored the risk of com-
plications and response to oral medica-
tion, a cohort study linking primary care
and genetic data. The second domain,
gastro-oesophageal reflux disease
(GORD), included two use cases link-
ing primary care and cancer registry
data. One was a randomised control-
led trial of on-demand compared with
continuous use of proton pump inhibi-
tors (PPIs) a class of anti-indigestion
medicine. The other  was a nested case-
control study to explore the association
of GORD symptoms and the use of PPIs
with developing Barrett’s disease and
cancer of the oesophagus.
6   Defining the Scope of the
Information Needed from
Candidate Databases
We def ined the scope of the informa-
tion we would need to collect from can-
didate data providers; though asking
stakeholders to def ine what they con-
sidered to be essential requirements.
7   Business Process Modelling
Late on in our process we introduced
Business Process Modelling Notation
(BPMN) to define business requirements.
The stakeholder analysis informed us
these were important and they were ne-
glected in our initial programme design.
8   Sensitivity Analysis
We collected data about peer review pub-
lications produced by data repositories
being considered for inclusion in the
TRANSFoRm research studies. We did
this because that track record may be
predictive of future success. Finally, we
conducted a review of what elements of
our requirements analysis contributed to
our final specifications.
9   Ethical Considerations
This investigation did not involve any
direct contacts with patients or access
to medical records. No specif ic ethical
consent was deemed necessary.
Results
1   Stakeholder Analysis
We identif ied key stakeholders and
used a mind map to capture key con-
cepts (Figure 3) and summarised their
views in a stakeholder analysis grid
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Fig. 3   Mind map of stakeholders and issues
Table 1   Summary stakeholder analysis
 
1
2
3
4
Project Stakeholder
End users / researchers
Direct Data providers
(Data repositories and
networks)
Indirect Data providers
(Citizens, Patients, GPs)
Study team & funders
External experts
Specific Information Needs
Will data deliver study?
1. Unique linked patient records;
2. Case definition (Coding);
3. Outcome variables;
4. Inclusion & exclusion criteria
5. Study specific - controls,
randomisation, patient link
1. Return on investment of time -
studies, funding
2. Strategic interest
1. About use of their data
2. Maintenance of confidentiality/privacy
1. Progress towards achieving milestones
in project
2. Requirements of next steps in project
3. Meeting own institutions objectives
Academic interest in how and whether
this can be done
Best Source of Information
Needed
1. Own study protocol
2. Relevant use case
3. Track record of provider
Who will get a funded study?
Track record of researcher
Network / repository owner
1. TRANSFoRm study protocol
2.  Work package outputs
Simulations & studies - proof of
concept
Planned Method of Delivery
Require a third party to link data
Engage once  benefits
Largely via network / repository
1. Connecting data via TRANSFoRm
engine
2. Provenance engine
Informal input / advice re: projects
Timing Considerations
Want to avoid any delays in
research process
Have standard processable
outputs readily available
Challenging to change
arrangement
Critical nature of dependencies
from previous work packages
Variable
picture" and focused on project mile-
stones and repor ts to funders. There
were also inevitable changes in
project scope. Important changes for
the requirements analysis were the in-
clusion of cancer registries and adop-
tion of contextual provenance  with
the requirement to describe "How
that data came to be ." This change
in scope of provenance extended be-
yond what is def ined within the use
cases as it included influences prior
to recording.
The Informatics working g roup
members also broadened the scope
of the requirements.  They argued
that human factors and the wider
context of the health system, legal
and socio-cultural factors all influence
the process and should be included
in the requirements analysis [23, 24].
Their view was that contextual prov-
enance whilst important could only
apply to data that were recorded and
that a broader contextual overview
might better explain why data were
present or not.
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2   Use Case Analysis
We compared the use cases developed
for the TRANFoRm project with the
reference model schema we constructed
for a generic research study to identify
specif ic data requirements.
The diabetes use case varied little
from the reference model schema other
than we needed to add a prescribing
database. The UML model reflected that
this was a cohort study where a subset
of the population is identif ied (Figure
4(a)). The GORD use cases were more
complex, also reflecting the study type
(Figures 4(b) and 4(c)).
4(a) In this use case genetic and
primary care data about type-2 dia-
betes (T2D) are linked; <<uses>> des-
ignates that the information is required
at least once. 4(b) Case-control study
to exploring the associate of GORD,
use of PPIs, and oesophageal adeno-
carcinoma. 4(c) GORD RCT compar-
ing on-demand and regular PPI
The diabetes study has an almost iden-
tical DFD to that in the reference model
schema (Figure 5(a)). The GORD case-
control study DFD (Figure 5(b)) only
differed from the diabetes study DFD as
a result of the addition of randomisation.
The data flows in the RCT were much
more complex and reflected a different
approach to collecting data (Figure 5(c)).
In this use case, the GP or the researcher
mined their EHR data to identify and
consent patients to participate at the be-
ginning of the study, whereas in the other
studies there is no GP-patient interaction.
3.  Scope of the Information
Required to Link Candidate
Databases:
We identif ied three levels of granular-
ity of information required to assess if
a data source could be used to partici-
pate in a research project (Table 2):
(1) Micro-level requirements were a de-
tailed description of the type data source,
the data itself, the potential for linkage
and achieving semantic interoperability
between data sources [42];
(2) Meso-level requirements included
reporting methods of data ex-
traction [43, 44], details of the
EHR systems used and their ar-
chitecture [45], audit trails that
might provide information about
data provenance, and the size of
the database;
(3) Macro-level issues related to the
nature of the health system and
socio-cultural issues.
Study specif ic requirements were de-
f ined by differences between the ref-
erence model and use cases.
4   Scope of the Business
Requirements
We identif ied and integrated into our
requirements analysis a number of busi-
ness requirements that went beyond the
data requirements for conducting a
study (Figure 6). Most of what we
framed as business requirements f it
within the scope of a research network.
The business process modelling was
critical in developing an understanding
of the lack of engagement, and how
concentration on the data model ignored
the need for a business case.
Fig. 4   UML use case model giving an overview research process for: (a) Diabetes (cohort study), (b) GORD (case control) and (c) GORD (randomised
controlled trial) use cases
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5   Sensitivity Analysis
We used publication of peer-reviewed
studies as an index of a functional busi-
ness process.  Eight of the ten data
providing stakeholders who provided
full information could provide evi-
dence of work produced from their
data and indexed in the bibliographic
database Medline. Four data providers
estimated between 30 and 100 peer-
reviewed publications had been pub-
lished in the last five years. Of the re-
Fig. 5   DFD for the TRANSFoRm use cases
maining four, two estimated 11 to 20
and two estimated 2 to 5 publications.
6   Contributions to the Requirements
Analysis
Finally, we report how the different
inputs contributed to the f inal require-
ments analysis (Table 2). With the ex-
ception of socio-cultural issues, all the
requirements were identif ied by more
than one source.
Discussion
1   Principal Findings
The requirements for l inking com-
plex heterogeneous databases are ex-
tensive,  and failure to foresee the
business requirements resulted in
stake-holder disengagement.  In ad-
dition to the anticipated core data re-
quirements we have identif ied geo-
graphical and socio-cultural
requirements.  The use case,  data
driven model, helped def ine whether
a database was suitable to conduct a
par ticular research study. However,
we also required information about
the geographical overlap between
data repositories and readiness to par-
ticipate. We used a reference model
to identify generic as well as study
specif ic requirements.  Local lan-
guage and the regional nature of
some data repositories are additional
challenges to conducting interna-
tional research. Many of the success-
ful data collection systems were pro-
prietary and saw no reason to move
to more open methods and systems;
they believed this entailed risk and
expense but with no obvious benef it.
Only after we included BMPN in our
approach did we manage to ration-
alise and frame these requirements.
2   Implications of the Findings
The data requirements from the use
case analysis identif ied most data
needed to conduct research, but may
miss important business issues which
may constrain involvement.  Whilst
generic reference models for re-
search studies make sense of the
processes and data flows; the busi-
ness requirements of the data reposi-
tory owners and EHR vendors also
need to be modelled and met.  Re-
searchers who design data projects
that involve linking databases need
to make sure that they include in-
centives for participation otherwise
they risk low levels of engagement.
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One strategy to overcome this might
be creating a research network infra-
structure to register researchers and
data providers wishing to conduct
linked data studies that might pro-
vide a forum to facilitate and broker
solutions.
3   Comparison with the Literature
Linking heterogeneous data is challeng-
ing [46]. Use cases and UML have used
in research reporting adverse events in
clinical trials [47] and medical image
analysis pilots [48]. The OntoRAT toolkit
is a working example of the use of
ontologically driven systems [49]. Such
ontologically driven systems might best
be developed using object-orientated ap-
proaches as has been used in specialist
cancer management [50] and for check-
ing healthcare domain models [51].
Fig. 6   Detailed BPMN diagram to demonstrate the steps in ascertaining if a data source meets the business requirements
Table 2   Scope of data collection defined by the requirements analysis
Method &
control of data
extraction
Record system
& information
model
Data extracted
Demographics ID
Coded Data
Free-text
Data quality
Taxonomy of errors
associated with data
extraction
PCROM
Primary Care
Research Model
OpenEHR
Archetypes
www.openehr.org
Use case/protocol and
EPR architecture
ISO 11179
Metadata
http//metadata-
standards.org/11179
Meso-
level
Macro-
level
Organisational
level
Socio-cultural
factors
Primary Health
Care System
Socio-cultural
dimensio to what is
disease & presented
to primary care
Wider social
influences
On data availability
/ consent & access
to data
Fragmentation
of care
Separate providers
Coverage
Univesal/limited
Management of
Ambulatory care
sensitive conditions
Study
specific
Use-Case
compatibility
Diabetes study
Primary care &
genetic data
Barrets
oesophagus &
medicatoin
Micro-
level
Dara source /
Data type
Data
Interoperability
level
Genetic data
Primary Care /
Cancer Registry
data
All types of data
CDISC Clinical Data
Exchange Consortium
- www.cdisc.org
BRIDG Biomedical
Research Integrated
Domain Group -
www.bridg.org
HL7 Health Level
Seven - www.hl7.org
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Although widely used in software
engineering, the modelling tools we
propose to be used have been little
used in the health domain; despite
calls that they should be made more
accessible to health researchers [52].
DFD have been used little in health
care though they have been proposed
as a component of object orientated
health information management system
[53]. UML has been used the most. It
has been proposed as a tool for avoid-
ing integration problems [54] and for
modelling research studies [55], but
thus far with little evidence of ben-
ef it [56]. BPMN is now considered
an appropriate tool for modelling
digital pathology and care pathways
but has not been proposed for mod-
elling health research [57, 58].
4   Limitations of the Method
We could have just used UML. The
UML alternatives are either to de-
velop a domain model or use UML
state-machine or f inite state machine
diagrams [26-8]. Business architec-
ture models (BAM) have been applied
to the life sciences to help generate
UML models [59]; and other tailored
packages have been used to generate
UML diagrams for bioinformatics
research [60] and to generate genotype-
phenotype maps [61].
Our requirements analysis pro-
duced a non-executable set of mod-
els and methods for sorting candi-
date databases into those potentially
useable in linked data research. We
did not def ine these steps in suff i-
cient detail to be able to set them out
using business process executable
language (BPEL) specif ications [62],
BPEL has been used within health-
care [63],  and might help reduce
barriers to potential researchers and
data providers.
5   Call for Further Research
The user requirements developed need
to be tested prospectively. Where the
required activities can be published with
clearly def ined interfaces it will be
possible to produce an executable model
such as BPEL.
Conclusions
We def ined generic user requirements
for research studies l inking health
data based on a reference model,
which can be extended for specif ic
studies;  using UML use case dia-
g rams and DFD. Additionally we
have identif ied geographical require-
ments and the importance of socio-
cultural context. However, the key
learning from this exercise is the im-
portance of modelling the business
process and including this within a re-
quirements analysis. Failure to include
and recognise the importance of mod-
elling the business process as part of
requirements analysis risks lack of en-
gagement by intended participants and
increases the risk of project failure.
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